JAM
ZOM

Jupiter Asset Management’s Zomedica Corp. ZOM Stock Holding History

Jupiter Asset Management’s Portfolio ZOM Stock Details ZOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-197,728
Closed -$61K – 644
2021
Q4 		$61K Buy
+197,728
New +$89.1K ﹤0.01% 544

Other funds holding ZOM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BBHC
Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Swiss National Bank
Swiss National Bank Zurich, Switzerland $174B AUM 30.96% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Jupiter Asset Management's ZOM Position: Q1 2022 in Review

Jupiter Asset Management sold out of Zomedica Corp. (ZOM) in Q1 2022, closing a stake of 197,728 shares — an estimated $61K sold.

Jupiter Asset Management first reported a position in ZOM in Q4 2021 and held it in 1 quarter. The position peaked at $61K in Q4 2021. 110 funds tracked by Wall St. Rank hold ZOM as of Q1 2022.

  • Jupiter Asset Management reported no remaining Zomedica Corp. position as of Q1 2022 after selling out during the quarter.
  • Jupiter Asset Management sold 197,728 Zomedica Corp. shares in Q1 2022, an estimated $61K.
  • Jupiter Asset Management first reported a position in Zomedica Corp. in Q4 2021 and held it in 1 quarter.
  • Jupiter Asset Management's Zomedica Corp. position peaked at $61K in Q4 2021.
  • 110 funds tracked by Wall St. Rank held Zomedica Corp. as of Q1 2022.

Based on Jupiter Asset Management's 13F filing for Q1 2022, filed 11 May 2022.